The board of directors of the Israeli pharmaceutical manufacturer Teva made the final choice of the new executive director of the company. They became Kaare Schultz (Kaare Schultz), the former leader of the Danish Lundbeck.
"Teva" remained without a permanent executive director in February this year after the departure of Erez Wigodman, who led the company since 2014. Since the departure of Vigodman, the temporary acting head of the company was Yitzhak Petersburg.
Schulz led Lundbeck in 2015. Prior to that, he worked in Novo Nordisk (since 1989), at the time of his departure from Novo Nordisk, Schulz served as the company's operational director.